Evidence map›Paper›PMID 35647885›Full record

ArticleJournal of the American Society for Mass Spectrometry2022

Investigation of Tryptic Protein Digestion in Microdroplets and in Bulk Solution.

Yongling Ai, Jeffrey Xu, Harsha P Gunawardena, Richard N Zare, Hao Chen

Abstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yongling AiDepartment of Chemistry & Environmental Science, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.ORCID 0000-0003-4458-2041
Jeffrey XuDepartment of Chemistry & Environmental Science, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.
Harsha P GunawardenaJanssen Research & Development, The Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania 19477, United States.ORCID 0000-0003-3245-3293
Richard N ZareDepartment of Chemistry, Stanford University, Stanford, California 94305-5080, United States.ORCID 0000-0001-5266-4253
Hao ChenDepartment of Chemistry & Environmental Science, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.ORCID 0000-0001-8090-8593

Funding

Development of Electrochemistry-Assisted Quantitative Mass Spectrometry for Proteomics ResearchR15GM137311 · NIGMS · NEW JERSEY INSTITUTE OF TECHNOLOGY · PI CHEN, HAO · 2020 to 2020
$379k
NIGMS NIH HHS R15 GM137311
6 · The paper itself

Abstract

Recent studies have shown that ultrafast enzymatic digestion of proteins can be achieved in microdroplet within 250 μs. Further investigation of peptides resulting from microdroplet digestion (MD) would be necessary to evaluate it as an alternative to the conventional bulk digestion for bottom-up and biotherapeutic protein characterization. Herein we examined and compared protein tryptic digestion in both MD and bulk solution. In the case of MD of β-lactoglobulin B, the preservation of long peptides was observed due to the short digestion time. In addition, MD is applicable to digest both high- and low-abundance proteins in mixture. In the case of digesting NIST 8671 mAb antibody containing a low level of commonly encountered host cell protein (HCP) PLBL2 (mAb:PLBL2 = 100:1 by weight), MD produced lower levels of digestion-induced chemical modifications of asparagine/glutamine deamidation, compared with overnight digestion. No significant difference between MD and bulk digestion was observed in terms of trypsin digestion specificity based on examination of semi- and unspecific-cleaved peptides. Our study suggests that MD, a fast digestion approach, could be adopted for bottom-up proteomics research and for peptide mapping of mAbs to characterize site-specific deamidation and glycosylation, for the purpose of development of biopharmaceuticals.

Indexed as

Antibodies, MonoclonalPeptidesAmino Acid SequenceChromatography, LiquidProteolysisTrypsinAntibodies, MonoclonalPeptidesTrypsinantibodydeamidationenzymatic digestionmicrodroplet reaction

Identifiers

PMID35647885
PMCPMC10512443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.